4886
JP:CO:ASKA-PHARMA-HD
あすか製薬ホールディングス株式会社
- Stock
Last Close
2,219.00
25/09 06:15
Market Cap
67.99B
Beta: -
Volume Today
58.40K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 9.40B - | 10.30B 9.61% | 11.25B 9.19% | 10.90B 3.08% | 11.28B 3.41% | 12.94B 14.73% | 14.02B 8.40% | 14.21B 1.31% | 16.37B - | ||
average payables | 4.19B - | 5.46B 30.32% | 5.32B 2.65% | 4.55B 14.54% | 5.26B 15.77% | 6.16B 17.08% | 6.57B 6.67% | 6.25B 4.96% | 2.98B - | ||
average receivables | 14.85B - | ||||||||||
book value per share | 1.24K - | 1.28K 3.67% | 1.29K 0.68% | 1.38K 6.89% | 1.44K 4.24% | 1.48K 3.16% | 1.44K 2.80% | 1.52K 5.23% | 1.62K 6.62% | 1.78K 10.37% | |
capex per share | -65.47 - | -69.88 6.75% | -82.37 17.87% | -24.70 70.02% | -26.41 6.94% | -83.27 215.32% | -72.75 12.64% | -38.94 46.48% | -78.59 101.85% | -24.41 68.94% | |
capex to depreciation | -0.74 - | -1.07 44.95% | -1.12 4.20% | -0.28 75.29% | -0.31 12.65% | -0.90 188.83% | -0.55 39.04% | -0.33 38.95% | -0.82 146.65% | -0.24 71.04% | |
capex to operating cash flow | -0.69 - | -0.34 50.99% | 1.70 599.88% | -0.06 103.36% | -9.79 17,014.55% | -0.94 90.41% | 4.18 545.70% | -0.17 104.04% | -0.84 395.54% | -0.22 73.38% | |
capex to revenue | -0.05 - | -0.05 1.51% | -0.05 17.26% | -0.01 73.25% | -0.02 6.91% | -0.05 231.00% | -0.04 22.15% | -0.02 48.92% | -0.04 109.88% | -0.01 70.62% | |
cash per share | 249.15 - | 343.99 38.06% | 195.87 43.06% | 528.31 169.73% | 402.74 23.77% | 389.16 3.37% | 257.84 33.74% | 370.83 43.82% | 565.50 52.50% | 585.84 3.60% | |
days of inventory on hand | 150.21 - | 161.46 7.49% | 155.75 3.54% | 131.67 15.46% | 144.11 9.45% | 183.78 27.53% | 179.68 2.23% | 176.04 2.02% | 181.69 3.20% | 202.53 11.47% | |
days payables outstanding | 66.29 - | 97.32 46.80% | 52.98 45.56% | 65.43 23.52% | 63.36 3.17% | 93.26 47.19% | 77.29 17.13% | 79.07 2.31% | 37.62 52.43% | 32.50 13.61% | |
days sales outstanding | 93.38 - | 91.86 1.62% | |||||||||
debt to assets | 0.00 - | 0.01 318.48% | 0.06 497.18% | 0.04 33.14% | 0.03 30.12% | 0.16 497.24% | 0.17 7.97% | 0.17 2.30% | 0.17 1.30% | 0.14 14.09% | |
debt to equity | 0.00 - | 0.02 362.95% | 0.09 477.38% | 0.06 28.18% | 0.04 33.40% | 0.31 617.22% | 0.34 8.17% | 0.32 4.66% | 0.29 10.16% | 0.23 19.43% | |
dividend yield | 0.01 - | 0.01 0.03% | 0.01 0.19% | 0.01 0.06% | 0.01 0.31% | 0.01 0.59% | 0.01 0.51% | 0.01 21.33% | 0.01 10.82% | 0.01 19.38% | |
earnings yield | 0.01 - | 0.03 140.47% | 0.02 41.35% | 0.07 319.16% | 0.06 19.55% | 0.04 27.09% | 0.02 62.88% | 0.07 317.09% | 0.11 71.48% | 0.12 3.84% | |
enterprise value | 36.30B - | 33.94B 6.51% | 35.28B 3.95% | 26.06B 26.13% | 30.94B 18.72% | 30.25B 2.23% | 34.04B 12.53% | 30.91B 9.19% | 40.14B 29.87% | 34.46B 14.16% | |
enterprise value over ebitda | 11.48 - | 10.52 8.40% | 10.95 4.05% | 6.07 44.57% | 5.93 2.30% | 6.87 15.91% | 6.46 5.99% | 4.47 30.80% | 5.11 14.21% | 4.07 20.24% | |
ev to operating cash flow | 13.88 - | 5.94 57.17% | -26.15 540.00% | 2.16 108.26% | 407.08 18,744.07% | 12.08 97.03% | -69.18 672.69% | 4.73 106.83% | 14.12 198.89% | 10.28 27.20% | |
ev to sales | 0.92 - | 0.79 13.93% | 0.82 3.21% | 0.54 34.22% | 0.63 17.71% | 0.65 2.45% | 0.65 0.03% | 0.56 13.53% | 0.71 26.59% | 0.57 19.63% | |
free cash flow per share | 28.74 - | 135.28 370.75% | -130.75 196.65% | 407.05 411.33% | -23.71 105.83% | 5.46 123.01% | -90.14 1,751.81% | 191.76 312.73% | 15.37 91.98% | 85.23 454.37% | |
free cash flow yield | 0.02 - | 0.09 370.75% | -0.09 196.65% | 0.28 411.33% | -0.02 105.83% | 0.00 123.01% | -0.06 1,751.81% | 0.13 312.73% | 0.01 90.73% | 0.07 488.87% | |
graham net net | -208.66 - | -254.94 22.18% | -376.30 47.60% | -233.12 38.05% | -227.03 2.61% | -735.45 223.94% | -860.79 17.04% | -718.51 16.53% | 35.99 105.01% | 181.73 404.94% | |
graham number | 703.87 - | 1.11K 57.90% | 853.98 23.16% | 1.81K 111.67% | 1.66K 8.42% | 1.44K 13.28% | 862.38 39.93% | 1.81K 109.50% | 2.27K 25.72% | 2.36K 3.87% | |
income quality | 5.28 - | 4.79 9.43% | -1.92 140.21% | 4.10 312.92% | 0.03 99.22% | 1.44 4,411.37% | -0.76 152.80% | 2.41 418.03% | 0.46 80.87% | 0.63 35.65% | |
intangibles to total assets | 0.01 - | 0.01 32.03% | 0.06 522.36% | 0.05 7.94% | 0.05 4.65% | 0.19 270.58% | 0.17 9.24% | 0.14 14.93% | 0.07 48.46% | 0.05 30.97% | |
interest coverage | 85.63 - | 102.16 19.31% | |||||||||
interest debt per share | 4.18 - | 20.05 379.96% | 116.55 481.31% | 89.48 23.23% | 62.12 30.58% | 459.60 639.88% | 483.26 5.15% | 484.85 0.33% | 466.27 3.83% | 414.65 11.07% | |
inventory turnover | 2.43 - | 2.26 6.97% | 2.34 3.67% | 2.77 18.29% | 2.53 8.63% | 1.99 21.59% | 2.03 2.28% | 2.07 2.06% | 2.01 3.10% | 1.80 10.29% | |
invested capital | 0.00 - | 0.02 362.95% | 0.09 477.38% | 0.06 28.18% | 0.04 33.40% | 0.31 617.22% | 0.34 8.17% | 0.32 4.66% | 0.29 10.16% | 0.23 19.43% | |
market cap | 40.57B - | 40.66B 0.22% | 40.74B 0.19% | 40.82B 0.19% | 41.16B 0.83% | 41.23B 0.17% | 41.33B 0.24% | 41.42B 0.23% | 38.20B 7.79% | 36.34B 4.87% | |
net current asset value | 8.79B - | 9.83B 11.92% | 5.36B 45.49% | 10.44B 94.83% | 12.12B 16.02% | -910M 107.51% | -1.34B 47.25% | 1.86B 238.81% | 15.15B 714.57% | 21.15B 39.61% | |
net debt to ebitda | -1.35 - | -2.08 54.33% | -1.69 18.69% | -3.44 102.80% | -1.96 43.02% | -2.49 27.39% | -1.38 44.51% | -1.52 9.83% | 0.25 116.25% | -0.22 190.00% | |
net income per share | 17.82 - | 42.86 140.47% | 25.14 41.35% | 105.37 319.16% | 84.77 19.55% | 61.80 27.09% | 22.94 62.88% | 95.69 317.09% | 141.85 48.24% | 138.66 2.24% | |
operating cash flow per share | 94.20 - | 205.16 117.79% | -48.38 123.58% | 431.75 992.49% | 2.70 99.38% | 88.73 3,189.13% | -17.39 119.60% | 230.70 1,426.47% | 93.97 59.27% | 109.64 16.68% | |
payables turnover | 5.51 - | 3.75 31.88% | 6.89 83.70% | 5.58 19.04% | 5.76 3.27% | 3.91 32.06% | 4.72 20.67% | 4.62 2.25% | 9.70 110.20% | 11.23 15.75% | |
receivables turnover | 3.91 - | 3.97 1.65% | |||||||||
research and ddevelopement to revenue | 0.10 - | 0.09 10.58% | 0.10 2.96% | 0.10 6.04% | 0.08 19.11% | 0.10 16.11% | 0.09 2.80% | ||||
return on tangible assets | 0.01 - | 0.02 108.75% | 0.01 36.68% | 0.05 263.29% | 0.04 19.23% | 0.03 31.29% | 0.01 62.67% | 0.04 294.17% | 0.06 44.95% | 0.05 7.85% | |
revenue per share | 1.42K - | 1.54K 8.38% | 1.55K 0.52% | 1.74K 12.07% | 1.74K 0.03% | 1.66K 4.73% | 1.86K 12.22% | 1.95K 4.79% | 1.87K 3.83% | 1.98K 5.69% | |
roe | 0.01 - | 0.03 131.95% | 0.02 41.75% | 0.08 292.13% | 0.06 22.83% | 0.04 29.33% | 0.02 61.81% | 0.06 296.34% | 0.09 39.03% | 0.08 11.43% | |
roic | 0.01 - | 0.03 136.23% | 0.01 46.12% | 0.04 170.88% | 0.05 33.69% | 0.03 42.18% | 0.02 33.85% | 0.05 141.96% | 0.05 9.83% | 0.06 13.49% | |
sales general and administrative to revenue | 0.28 - | 0.25 11.41% | 0.25 0.13% | 0.23 8.03% | 0.23 1.69% | 0.25 11.31% | 0.22 12.06% | ||||
shareholders equity per share | 1.24K - | 1.28K 3.67% | 1.29K 0.68% | 1.38K 6.89% | 1.44K 4.24% | 1.48K 3.16% | 1.44K 2.80% | 1.52K 5.23% | 1.62K 6.62% | 1.78K 10.37% | |
stock based compensation to revenue | |||||||||||
tangible asset value | 33.24B - | 36.03B 8.39% | 32.66B 9.35% | 36.02B 10.27% | 39.23B 8.90% | 28.12B 28.30% | 27.99B 0.48% | 32.62B 16.54% | 42.71B 30.94% | 50.07B 17.23% | |
tangible book value per share | 1.20K - | 1.29K 8.14% | 1.17K 9.53% | 1.29K 10.06% | 1.39K 8.00% | 996.56 28.43% | 989.40 0.72% | 1.15K 16.27% | 1.41K 22.75% | 1.64K 16.01% | |
working capital | 16.89B - | 17.32B 2.55% | 15.89B 8.26% | 20.81B 30.97% | 21.58B 3.71% | 19.83B 8.11% | 20.20B 1.88% | 23.20B 14.83% | 33.55B 44.63% | 36.11B 7.64% |
All numbers in (except ratios and percentages)